What price per share did Pharvaris (PHVS) use for Lu Peng’s withheld shares?

The company used a fair market value of $31.51 per share for the 109 withheld shares. This value applied on June 11, 2026, when the restricted stock units vested and the tax withholding was processed.

Pharvaris CMO has 109 shares withheld for taxes

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Pharvaris N.V. Chief Medical Officer Lu Peng reported a small share disposition tied to equity compensation. On the vesting of restricted stock units on June 11, 2026, 109 shares of common stock were withheld to cover tax withholding obligations at a fair market value of $31.51 per share. After this tax-withholding event, Lu Peng directly owns 65,748 shares of Pharvaris common stock, so the filing reflects routine administration of stock-based compensation rather than an open-market trade.

Insider Trade Summary

Exercise Price or Tax Liability: 109 shares

Exercise Price or Tax Liability 1 txn

Insider Lu Peng

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	109	$31.51	$3K

Holdings After Transaction: Common Stock — 65,748 shares (Direct)

Footnotes (1)

F1. Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units on June 11, 2026. The shares were withheld on June 11, 2026 at a fair market value of $31.51 per share.

Key Figures

Shares withheld for taxes: 109 shares Fair market value per share: $31.51 per share Shares owned after transaction: 65,748 shares

3 metrics

Shares withheld for taxes 109 shares Withheld to satisfy tax obligations on RSU vesting June 11, 2026

Fair market value per share $31.51 per share Value used for withheld shares on June 11, 2026

Shares owned after transaction 65,748 shares Direct Pharvaris common stock holdings after tax-withholding event

Key Terms

restricted stock units, tax withholding obligations, fair market value, Form 4

4 terms

restricted stock units financial

"upon the vesting of restricted stock units on June 11, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"shares withheld to satisfy tax withholding obligations upon the vesting"

fair market value financial

"withheld on June 11, 2026 at a fair market value of $31.51"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pharvaris (PHVS) report for Lu Peng?

Pharvaris reported that Chief Medical Officer Lu Peng had 109 shares withheld to cover tax obligations when restricted stock units vested on June 11, 2026. This was a compensation-related withholding, not an open-market stock sale.

Was the Pharvaris (PHVS) Form 4 a stock sale by Lu Peng?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were withheld by Pharvaris to satisfy Lu Peng’s tax obligations upon RSU vesting at a fair market value of $31.51 per share.

How many Pharvaris (PHVS) shares were withheld for Lu Peng’s taxes?

A total of 109 Pharvaris common shares were withheld to satisfy Lu Peng’s tax withholding obligations on June 11, 2026, in connection with the vesting of restricted stock units granted as part of his compensation.

What is Lu Peng’s Pharvaris (PHVS) shareholding after this Form 4?

After the tax-withholding transaction, Lu Peng directly holds 65,748 Pharvaris common shares. The filing indicates his continuing equity stake following the RSU vesting and related withholding event disclosed for June 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/15/2026 - 05:22 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lu Peng

(Last)

(First)

(Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON

MASSACHUSETTS

02421

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/11/2026		F		109⁽¹⁾	D	$31.51	65,748	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units on June 11, 2026. The shares were withheld on June 11, 2026 at a fair market value of $31.51 per share.

	/s/ Marnus Nel, Attorney-in-Fact for Peng Lu	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR